** Brokerage Piper Sandler says it expects lower EBITDA in Q4 2024 and 2025 for chemical companies due to structural issues in the EU and Asia; says U.S. operations may "carry most of the weight"
** Says it will be hard for the companies to generate significant earnings momentum over the next 12-18 months
** Piper Sandler downgrades Dow Chemical DOW.N and LyondellBasell LYB.N to 'neutral' from 'overweight', and cuts PTs to $53 from $60, and $95 from $112, respectively
** Expects Ecolab ECL.N (maintain "overweight", PT cut to $270 from $305) and Olin OLN.N (maintain "overweight", PT cut to $41 from $51), among others, to be in best position to expand earnings partially on lesser degree of overcapacity in their markets
** Brokerage says it does not expect a rebound in China's chemical demand growth and U.S. pricing and margins will not be enough to drive company earnings
** Says stimulus in China and the EU will have more gradual impact than anticipated and might not address overcapacity
(Reporting by Seher Dareen in Bengaluru)
((Seher.Dareen@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.